FROOME CLOSEMedical Technologies

Drug Calculator Health Economics Drug AE Drug Label Drug Sync← Main site

Froome Close

Medical Technologies

Overview Drug AE Drug Sync Drug Calculator Health Economics Contact froomeclose.com

© 2026 Froome Close. Clinical information is intended for use by qualified healthcare professionals only. Not a substitute for clinical judgement.

Health Economics — Froome Close

← Health Economics

Indolent lymphoma

Select a treatment setting

First-line/Induction

Advanced disease first-line therapy

First-line therapy

Consolidation

Consolidation after first-line therapy

Consolidation after subsequent lines of therapy

Early disease consolidation

Maintenance

Maintenance after first-line therapy

Maintenance after subsequent lines of therapy

Relapsed/Refractory/Later-line

Relapsed or refractory

Rituximab-refractory

Other

Early disease definitive therapy